Metoprolol disrupts inflammatory response of human cardiomyocytes via β-arrestin2 biased agonism and NF-κB signaling modulation
Aims: Recent evidence supports non-class cardioprotective effects of metoprolol against neutrophil-mediated ischemia-reperfusion injury during exacerbated inflammation. Whether metoprolol exerts direct anti-inflammatory effect on cardiomyocytes is unknown. Accordingly, we aimed to investigate the di...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | Biomedicine & Pharmacotherapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223016025 |
| _version_ | 1797630645075181568 |
|---|---|
| author | Fabrizio Ricci Andrea Di Credico Giulia Gaggi Giovanni Iannetti Barbara Ghinassi Sabina Gallina Brian Olshansky Angela Di Baldassarre |
| author_facet | Fabrizio Ricci Andrea Di Credico Giulia Gaggi Giovanni Iannetti Barbara Ghinassi Sabina Gallina Brian Olshansky Angela Di Baldassarre |
| author_sort | Fabrizio Ricci |
| collection | DOAJ |
| description | Aims: Recent evidence supports non-class cardioprotective effects of metoprolol against neutrophil-mediated ischemia-reperfusion injury during exacerbated inflammation. Whether metoprolol exerts direct anti-inflammatory effect on cardiomyocytes is unknown. Accordingly, we aimed to investigate the direct anti-inflammatory effects of metoprolol in a cellular model of human induced pluripotent stem cell-derived cardiomyocytes (hiCMs) and to explore the role of β-arrestin2 (β-ARR2) biased agonism signaling pathway. Methods and results: hiCMs were treated with TNF-α for 24 h, followed by 4-hour treatment with metoprolol or esmolol. Electrical response of hiCMs to β1-selective blockade was assessed by microelectrode arrays technology. The effect on inflammatory and adhesion molecule expression was evaluated in wild-type and β-ARR2 silenced hiCMs. To silence β-ARR2 expression, hiCMs were transfected with a specific small interfering RNA targeting β-ARR2 mRNA and preventing its translation.TNF-α stimulation boosted the expression of IκB, NF-κB, IL1β, IL6, and VCAM1 in hiCMs. TNF-α-treated hiCMs showed similar physiological responses to metoprolol and esmolol, with no difference in field potential duration and beat period recorded. Adding metoprolol significantly decreased inflammatory response patterns in wild-type hiCMs by dampening TNF-α induced expression of NF-κB, IL1β, and IL6, but not in β-ARR2-knockout hiCMs. A similar response was not observed in presence of β1-selective blockade with esmolol. Conclusions: Metoprolol exerts a non-class direct anti-inflammatory effect on hi-CMs. β1-selective blockade with metoprolol disrupts inflammatory responses induced by TNF-α and induces significant inhibition of NF-κB signaling cascade via β-ARR2 biased agonism. If confirmed at clinical level, metoprolol could be tested and repurposed to treat cardiac inflammatory disorders. |
| first_indexed | 2024-03-11T11:11:06Z |
| format | Article |
| id | doaj.art-fda641ffb29444cbbd8c996f95ead192 |
| institution | Directory Open Access Journal |
| issn | 0753-3322 |
| language | English |
| last_indexed | 2024-03-11T11:11:06Z |
| publishDate | 2023-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Biomedicine & Pharmacotherapy |
| spelling | doaj.art-fda641ffb29444cbbd8c996f95ead1922023-11-12T04:39:23ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-12-01168115804Metoprolol disrupts inflammatory response of human cardiomyocytes via β-arrestin2 biased agonism and NF-κB signaling modulationFabrizio Ricci0Andrea Di Credico1Giulia Gaggi2Giovanni Iannetti3Barbara Ghinassi4Sabina Gallina5Brian Olshansky6Angela Di Baldassarre7Department of Neuroscience, Imaging and Clinical Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy and University Cardiology Division, Heart Department, SS Annunziata University Hospital, Chieti, Italy; Department of Clinical Sciences, Lund University, 214 28 Malmö, SwedenDepartment of Medicine and Aging Sciences, and Reprogramming and Cell Differentiation Lab, Center for Advanced Studies and Technology (CAST), G. D'Annunzio University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Medicine and Aging Sciences, and Reprogramming and Cell Differentiation Lab, Center for Advanced Studies and Technology (CAST), G. D'Annunzio University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy and University Cardiology Division, Heart Department, SS Annunziata University Hospital, Chieti, ItalyDepartment of Medicine and Aging Sciences, and Reprogramming and Cell Differentiation Lab, Center for Advanced Studies and Technology (CAST), G. D'Annunzio University of Chieti-Pescara, 66100 Chieti, ItalyDepartment of Neuroscience, Imaging and Clinical Sciences, G.d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy and University Cardiology Division, Heart Department, SS Annunziata University Hospital, Chieti, ItalyUniversity of Iowa, Iowa City, IA, USADepartment of Medicine and Aging Sciences, and Reprogramming and Cell Differentiation Lab, Center for Advanced Studies and Technology (CAST), G. D'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy; Corresponding author at: Department of Medicine and Aging Sciences, ''G. D'Annunzio'' University of Chieti-Pescara, Via dei Vestini, 31, 66100 Chieti, Italy.Aims: Recent evidence supports non-class cardioprotective effects of metoprolol against neutrophil-mediated ischemia-reperfusion injury during exacerbated inflammation. Whether metoprolol exerts direct anti-inflammatory effect on cardiomyocytes is unknown. Accordingly, we aimed to investigate the direct anti-inflammatory effects of metoprolol in a cellular model of human induced pluripotent stem cell-derived cardiomyocytes (hiCMs) and to explore the role of β-arrestin2 (β-ARR2) biased agonism signaling pathway. Methods and results: hiCMs were treated with TNF-α for 24 h, followed by 4-hour treatment with metoprolol or esmolol. Electrical response of hiCMs to β1-selective blockade was assessed by microelectrode arrays technology. The effect on inflammatory and adhesion molecule expression was evaluated in wild-type and β-ARR2 silenced hiCMs. To silence β-ARR2 expression, hiCMs were transfected with a specific small interfering RNA targeting β-ARR2 mRNA and preventing its translation.TNF-α stimulation boosted the expression of IκB, NF-κB, IL1β, IL6, and VCAM1 in hiCMs. TNF-α-treated hiCMs showed similar physiological responses to metoprolol and esmolol, with no difference in field potential duration and beat period recorded. Adding metoprolol significantly decreased inflammatory response patterns in wild-type hiCMs by dampening TNF-α induced expression of NF-κB, IL1β, and IL6, but not in β-ARR2-knockout hiCMs. A similar response was not observed in presence of β1-selective blockade with esmolol. Conclusions: Metoprolol exerts a non-class direct anti-inflammatory effect on hi-CMs. β1-selective blockade with metoprolol disrupts inflammatory responses induced by TNF-α and induces significant inhibition of NF-κB signaling cascade via β-ARR2 biased agonism. If confirmed at clinical level, metoprolol could be tested and repurposed to treat cardiac inflammatory disorders.http://www.sciencedirect.com/science/article/pii/S0753332223016025MetoprololBiased agonismβ-arrestinCardiomyocyteInflammation |
| spellingShingle | Fabrizio Ricci Andrea Di Credico Giulia Gaggi Giovanni Iannetti Barbara Ghinassi Sabina Gallina Brian Olshansky Angela Di Baldassarre Metoprolol disrupts inflammatory response of human cardiomyocytes via β-arrestin2 biased agonism and NF-κB signaling modulation Biomedicine & Pharmacotherapy Metoprolol Biased agonism β-arrestin Cardiomyocyte Inflammation |
| title | Metoprolol disrupts inflammatory response of human cardiomyocytes via β-arrestin2 biased agonism and NF-κB signaling modulation |
| title_full | Metoprolol disrupts inflammatory response of human cardiomyocytes via β-arrestin2 biased agonism and NF-κB signaling modulation |
| title_fullStr | Metoprolol disrupts inflammatory response of human cardiomyocytes via β-arrestin2 biased agonism and NF-κB signaling modulation |
| title_full_unstemmed | Metoprolol disrupts inflammatory response of human cardiomyocytes via β-arrestin2 biased agonism and NF-κB signaling modulation |
| title_short | Metoprolol disrupts inflammatory response of human cardiomyocytes via β-arrestin2 biased agonism and NF-κB signaling modulation |
| title_sort | metoprolol disrupts inflammatory response of human cardiomyocytes via β arrestin2 biased agonism and nf κb signaling modulation |
| topic | Metoprolol Biased agonism β-arrestin Cardiomyocyte Inflammation |
| url | http://www.sciencedirect.com/science/article/pii/S0753332223016025 |
| work_keys_str_mv | AT fabrizioricci metoprololdisruptsinflammatoryresponseofhumancardiomyocytesviabarrestin2biasedagonismandnfkbsignalingmodulation AT andreadicredico metoprololdisruptsinflammatoryresponseofhumancardiomyocytesviabarrestin2biasedagonismandnfkbsignalingmodulation AT giuliagaggi metoprololdisruptsinflammatoryresponseofhumancardiomyocytesviabarrestin2biasedagonismandnfkbsignalingmodulation AT giovanniiannetti metoprololdisruptsinflammatoryresponseofhumancardiomyocytesviabarrestin2biasedagonismandnfkbsignalingmodulation AT barbaraghinassi metoprololdisruptsinflammatoryresponseofhumancardiomyocytesviabarrestin2biasedagonismandnfkbsignalingmodulation AT sabinagallina metoprololdisruptsinflammatoryresponseofhumancardiomyocytesviabarrestin2biasedagonismandnfkbsignalingmodulation AT brianolshansky metoprololdisruptsinflammatoryresponseofhumancardiomyocytesviabarrestin2biasedagonismandnfkbsignalingmodulation AT angeladibaldassarre metoprololdisruptsinflammatoryresponseofhumancardiomyocytesviabarrestin2biasedagonismandnfkbsignalingmodulation |